BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 223 filers reported holding BIONTECH SE in Q1 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $891,378 | +19.3% | 8,205 | +18.5% | 0.00% | 0.0% |
| Q2 2023 | $747,377 | -23.4% | 6,925 | -11.6% | 0.00% | -50.0% |
| Q1 2023 | $975,603 | -23.7% | 7,831 | -8.1% | 0.00% | -33.3% |
| Q4 2022 | $1,279,091 | +3.2% | 8,517 | -7.3% | 0.00% | 0.0% |
| Q3 2022 | $1,239,000 | -15.2% | 9,183 | -6.4% | 0.00% | 0.0% |
| Q2 2022 | $1,461,000 | -20.3% | 9,808 | -1.1% | 0.00% | -25.0% |
| Q1 2022 | $1,832,000 | -79.1% | 9,922 | -70.8% | 0.00% | -76.5% |
| Q4 2021 | $8,747,000 | -14.9% | 33,949 | -9.8% | 0.02% | -19.0% |
| Q3 2021 | $10,275,000 | +18.4% | 37,655 | -2.8% | 0.02% | +10.5% |
| Q2 2021 | $8,676,000 | +378.3% | 38,757 | +133.2% | 0.02% | +375.0% |
| Q1 2021 | $1,814,000 | +91.6% | 16,623 | +43.0% | 0.00% | +33.3% |
| Q4 2020 | $947,000 | +105.4% | 11,624 | +74.6% | 0.00% | +200.0% |
| Q3 2020 | $461,000 | +880.9% | 6,656 | +845.5% | 0.00% | – |
| Q2 2020 | $47,000 | – | 704 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |